-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In primary cardiovascular disease prevention , a recent meta-analysis of randomized trials showed that daily low-dose aspirin was associated with a proportional 11% reduction in the risk of major vascular events (including a 19% reduction in ischemic stroke ), but the risk of major bleeding was reduced by 19%.
Vascular Prevention of Stroke
Recently, a research article was published in Eur Heart J, an authoritative journal in the cardiovascular field.
diabetes
The cognitive study included 15,427 ASCEND participants with no documented dementia at baseline whose primary outcome was "generalized dementia," including dementia, cognitive impairment, or confusion
diagnosis
A similar proportion of participants in the aspirin and placebo groups developed extensive dementia outcomes, 548 (7.
Thus, aspirin did not have a large proportional effect on dementia risk
Aspirin did not have a large proportional effect on dementia risk
Original source:
Sarah Parish, et al.
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial